Tucatinib Completed Phase 1 Trials for Hepatic Impairment Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03722823A Safety Study of Tucatinib in Healthy and Hepatically-Impaired Subjects